These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35854066)

  • 1. Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects.
    Kamble SH; Berthold EC; Kanumuri SRR; King TI; Kuntz MA; León F; Mottinelli M; McMahon LR; McCurdy CR; Sharma A
    AAPS J; 2022 Jul; 24(5):86. PubMed ID: 35854066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method.
    Berthold EC; Kamble SH; Raju KS; King TI; Popa R; Sharma A; León F; Avery BA; McMahon LR; McCurdy CR
    J Pharm Biomed Anal; 2021 Feb; 194():113778. PubMed ID: 33277117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism studies of the Kratom alkaloid speciociliatine, a diastereomer of the main alkaloid mitragynine, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    Anal Bioanal Chem; 2011 Mar; 399(8):2747-53. PubMed ID: 21249338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
    Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
    Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
    Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
    Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.
    Kamble SH; Berthold EC; King TI; Raju Kanumuri SR; Popa R; Herting JR; León F; Sharma A; McMahon LR; Avery BA; McCurdy CR
    J Nat Prod; 2021 Apr; 84(4):1104-1112. PubMed ID: 33620222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolites and potential biomarkers of kratom in urine.
    Basiliere S; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
    Tanna RS; Tian DD; Cech NB; Oberlies NH; Rettie AE; Thummel KE; Paine MF
    J Pharmacol Exp Ther; 2021 Jan; 376(1):64-73. PubMed ID: 33093187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1049-55. PubMed ID: 21450536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
    Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
    J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.
    Obeng S; Kamble SH; Reeves ME; Restrepo LF; Patel A; Behnke M; Chear NJ; Ramanathan S; Sharma A; León F; Hiranita T; Avery BA; McMahon LR; McCurdy CR
    J Med Chem; 2020 Jan; 63(1):433-439. PubMed ID: 31834797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1).
    Melchert PW; Zhang Q; Mukhopadhyay S; Kanumuri SRR; McCurdy CR; Markowitz JS
    Chem Biol Interact; 2023 Oct; 384():110715. PubMed ID: 37716419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical Characterization of Mitragyna speciosa Alkaloid Extract and Mitragynine using In Vitro High Throughput Assays.
    Kong WM; Chik Z; Mohamed Z; Alshawsh MA
    Comb Chem High Throughput Screen; 2017; 20(9):796-803. PubMed ID: 29076424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.
    Zhang M; Sharma A; León F; Avery B; Kjelgren R; McCurdy CR; Pearson BJ
    PLoS One; 2022; 17(4):e0259326. PubMed ID: 35472200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines.
    Domnic G; Jeng-Yeou Chear N; Abdul Rahman SF; Ramanathan S; Lo KW; Singh D; Mohana-Kumaran N
    J Ethnopharmacol; 2021 Oct; 279():114391. PubMed ID: 34224811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline.
    Manda VK; Avula B; Ali Z; Khan IA; Walker LA; Khan SI
    Planta Med; 2014 May; 80(7):568-76. PubMed ID: 24841968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for Kratom alkaloids in fingernail clippings - not only mitragynine.
    Ameline A; Gheddar L; Arbouche N; Blanchot A; Raul JS; Kintz P
    J Pharm Biomed Anal; 2024 Jun; 243():116078. PubMed ID: 38489958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.